• Medical Translation
    • Medical Translation Services
      • COVID-19 Emergency Response Team
      • CTD/eCTD Submission
      • Linguistic Validation
      • eLearning & Training
      • Back Translation
      • Creative Communication
      • Terminology Management
      • Software Localization
      • Medical Document Translation Services
      • Linguistic Testing
      • Machine Translation Post-Editing
      • In-Country Review
      • Multilingual Desktop Publishing (DTP)
      • Technical Translation
      • Pharmacovigilance
      • Clinical Studies
      • Patient Recruitment
  • Industries
    • Medical Devices
    • Hospital Translation
    • Chemical Translations
    • In-Vitro Diagnostic Devices
    • Pharmaceuticals
    • Biotechnology
    • Health Science Legal Translation Services
    • Government, NGO & Non-Profit
  • Interpretation
    • Interpretation Services
      • CDE Pre IND/NDA Meeting
      • Medical Conferences
      • Phone Interpretation
      • Video Interpretation
  • Executive Management
  • HealthFirst 100
    • About HealthFirst 100
      • Health
      • Articles
      • News
      • White Papers & Case Studies
  • CSOFT International
  • English
    • 简体中文
    • Español
  • CSOFT International
  • News & Events
  • Careers
  • Contact
  • English
    • 简体中文 (Chinese (Simplified))
    • Español (Spanish)
  • CSOFT International
  • CSOFT International
  • CSOFT International
  • CSOFT International
CSOFT Health Sciences
  • Medical Translation
    • Medical Translation Services
      • COVID-19 Emergency Response Team
      • CTD/eCTD Submission
      • Linguistic Validation
      • eLearning & Training
      • Back Translation
      • Creative Communication
      • Terminology Management
      • Software Localization
      • Medical Document Translation Services
      • Linguistic Testing
      • Machine Translation Post-Editing
      • In-Country Review
      • Multilingual Desktop Publishing (DTP)
      • Technical Translation
      • Pharmacovigilance
      • Clinical Studies
      • Patient Recruitment
  • Industries
    • Medical Devices
    • Hospital Translation
    • Chemical Translations
    • In-Vitro Diagnostic Devices
    • Pharmaceuticals
    • Biotechnology
    • Health Science Legal Translation Services
    • Government, NGO & Non-Profit
  • Interpretation
    • Interpretation Services
      • CDE Pre IND/NDA Meeting
      • Medical Conferences
      • Phone Interpretation
      • Video Interpretation
  • Executive Management
  • HealthFirst 100
    • About HealthFirst 100
      • Health
      • Articles
      • News
      • White Papers & Case Studies
  • CSOFT International
  • English
    • 简体中文
    • Español
Select Page
NICE Reverses Disapproval of AstraZeneca’s Lung Cancer Therapy Tagrisso

NICE Reverses Disapproval of AstraZeneca’s Lung Cancer Therapy Tagrisso

Sep 11, 2020 | News, Regulatory

The National Institute for Health and Care Excellence (NICE) originally rejected global biopharmaceutical company AstraZeneca’s lung cancer therapy Tagrisso (Osimertinib), but has since decided to reverse its initial decision. NICE initially did not recommend Tagrisso...
FDA Approves Expansion of Remdesivir for Hospitalized COVID-19 Patients

FDA Approves Expansion of Remdesivir for Hospitalized COVID-19 Patients

Aug 31, 2020 | News, Regulatory

Gilead, a research-based biopharmaceutical company, has reported that their new antiviral treatment for COVID-19 Remdesivir, has just been granted an expansion on emergency use authorization (EUA) by the FDA for all patients hospitalized due to COVID-19. Originally...
The United States Grants $628 Million Contract with Emergent for COVID-19

The United States Grants $628 Million Contract with Emergent for COVID-19

Jun 1, 2020 | News, Regulatory

The Department of Health and Human Services granted Emergent BioSolutions a $628 million contract under the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal agency that funds disease-fighting technology in efforts to increase the...
China Finalized the Trade Agreement for Patent Drug with the U.S.

China Finalized the Trade Agreement for Patent Drug with the U.S.

Feb 4, 2020 | News, Regulatory

Trade Agreement On January 16, 2020 the U.S. and China finalized the trade agreement that specifies the patent protection rules for drugs. Under the patent protection, biopharmaceutical companies can fill out an application and the term of each new patent is 20 years....

Recent Posts

  • FDA Clears IND Application for Flexion Therapeutics’ FX301
  • FDA Approves Targeted Treatment for Duchenne Muscular Dystrophy
  • FDA Partially Rescinds Two Supplemental Biologics License Applications
  • Sinopharm Unit and CanSinoBio apply for Public Use Approval of COVID-19 Vaccine in China
  • FDA Makes Recommendations for COVID-19 Variants

Topics

  • CFDA
  • Classification System
  • Clinical Trials
  • e-Labeling
  • e-Learning
  • EMA
  • Events
  • FDA
  • Globalization
  • Health
  • Healthcare
  • In-Country Review
  • Innovation
  • Interpretation
  • Language Service Provider
  • Linguistic Validation
  • Machine Translation
  • Medical Translation
  • Medical Writing
  • Mistranslations
  • Mobile Translation
  • News
  • Pharmaceuticals
  • Quality
  • Regulatory
  • Resources
  • Social Media
  • Special stories
  • Terminology
  • Transcreation
  • Website Translation
  • Translation
  • CTD/eCTD Submission
  • Clinical Studies
  • Clinical Trials
  • Linguistic Validation
  • Back Translation
  • Medical Writing
  • eLearning & Training
  • Creative Communication
  • Terminology Management
  • Interpretation
  • CDE Pre IND/NDA Meeting
  • Medical Conferences
  • Over the Phone
  • Medical Writing
  • Regulatory Writing
  • Medico-Marketing
  • Publication Writing
  • Medical Writing Safety Writing
  • Lay Summaries
  • Informed Consent Form Translation
  • Patient Safety Narratives
  • Advisory Boards
  • Summaries of Safety
  • Asia Regulatory Services
  • Asia Market Access
  • Asia Regulatory Strategy
  • Clinical Trials in Asia
Environmental Responsibility and Sustainability at CSOFT
    ISO 9001 and ISO 13485 Certified © 2021 CSOFT International, Inc.    Terms of Use    Privacy Policy